Haleon (HLN) Goodwill & Intangibles (2021 - 2025)
Haleon (HLN) posted Goodwill & Intangibles of $44.9 billion for Q4 2025, up 1.61% on a QoQ basis from $44.2 billion in Q4 2024, and up 1.61% year-over-year from $44.2 billion in Q4 2024.
Haleon (HLN) Goodwill & Intangibles (2021 - 2025) Analysis & Trends
Haleon's Goodwill & Intangibles history runs 5 years deep, the most recent figure standing at $44.9 billion for Q4 2025.
- Quarterly Goodwill & Intangibles rose 1.61% year-over-year to $44.9 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $44.9 billion (up 1.61% YoY) and the FY2025 annual result came in at $44.5 billion, up 1.13% from the prior year.
- Goodwill & Intangibles was $44.9 billion for Q4 2025 at Haleon, up from $44.2 billion in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $44.9 billion in Q4 2025 and bottomed at $10.1 billion in Q4 2023.
- A 5-year average of $28.2 billion and a median of $34.0 billion in 2023 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2022 — Goodwill & Intangibles dropped 11.75% — and 2024, when it jumped 339.02%.
- Haleon's Goodwill & Intangibles stood at $12.1 billion in 2021, then dropped by 11.75% to $10.6 billion in 2022, then declined by 5.43% to $10.1 billion in 2023, then soared by 339.02% to $44.2 billion in 2024, then advanced by 1.61% to $44.9 billion in 2025.
- Business Quant data shows HLN's Goodwill & Intangibles at $44.9 billion in Q4 2025, $44.2 billion in Q4 2024, and $33.3 billion in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn |
| 3 | Zoetis | 32.67 Bn | 30.73 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.69 Bn | 23.63 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.12 Bn | 20.97 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.24 Bn | 18.44 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.83 Bn | 16.51 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 44.88 Bn |
| Dec 31, 2024 | 44.17 Bn |
| Jun 30, 2024 | 33.28 Bn |
| Dec 31, 2023 | 10.06 Bn |
| Jun 30, 2023 | 34.63 Bn |
| Dec 31, 2022 | 10.64 Bn |
| Jun 30, 2022 | 35.94 Bn |
| Dec 31, 2021 | 12.06 Bn |